Pamela Carrington-Tribble, DO
Family Medicine · Half Moon Bay, CANPI 1174544027
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Novo Nordisk at 36.8% of the total. Reporting peaked in 2021 at $289 and has fallen 72.6% since, to $79 in 2022.
Across 20 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$141
- Mylan Specialty L.p.$53
- Merck$35
- Dynavax Technologies Corporation$27
- Bayer$23
- GSK$22
- plus $82 from 5 others
What the payments were for
- Food & beverage$382100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $141 |
| Mylan Specialty L.p. | 3 | $53 |
| Merck | 2 | $35 |
| Dynavax Technologies Corporation | 1 | $27 |
| Bayer | 1 | $23 |
| GSK | 1 | $22 |
| AbbVie | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$382 in reported general payments places this provider in the 55th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,472 |
| PaxlovidNirmatrelvir/Ritonavir | 11 | $1,413 |
| Azelastine Hcl | 17 | $370 |
| Diclofenac Sodium | 15 | $222 |
| Famotidine | 21 | $191 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $172 |
| Ondansetron OdtOndansetron | 11 | $93 |
| Ciprofloxacin Hcl | 21 | $93 |
| Cephalexin | 17 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $54 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Half Moon Bay
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.